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Abstract
Background: Tricuspid valve (TV) regurgitation (TR) is a common complication of pulmonary hypertension and right-sided
congenital heart disease, associated with increased morbidity and mortality. Estimation of TR severity by echocardiography
and conventional cardiovasvular magnetic resonance (CMR) is not well validated and has high variability. 4D velocity-
encoded (4D-flow) CMR was used to measure tricuspid flow in patients with complex right ventricular (RV) geometry and
varying degrees of TR. The aims of the present study were: 1) to assess accuracy of 4D-flow CMR across the TV by
comparing 4D-flow CMR derived TV effective flow to 2D-flow derived effective flow across the pulmonary valve (PV); 2) to
assess TV 4D-flow CMR reproducibility, and 3) to compare TR grade by 4D-flow CMR to TR grade by echocardiography.
Methods: TR was assessed by both 4D-flow CMR and echocardiography in 21 healthy subjects (41.2 ± 10.5 yrs., female 7
(33%)) and 67 RV pressure-load patients (42.7 ± 17.0 yrs., female 32 (48%)). The CMR protocol included 4D-flow
CMR measurement across the TV, 2D-flow measurement across the PV and conventional planimetric measurements.
TR grading on echocardiographic images was performed based on the international recommendations. Bland-Altman
analysis and intra-class correlation coefficients (ICC) were used to asses correlations and agreement.
Results: TV effective flow measured by 4D-flow CMR showed good correlation and agreement with PV effective flow
measured by 2D-flow CMR with ICC = 0.899 (p < 0.001) and mean difference of −1.79 ml [limits of agreement −20.39 to
16.81] (p = 0.084). Intra-observer agreement for effective flow (ICC = 0.981; mean difference − 1.51 ml [−12.88 to 9.86])
and regurgitant fraction (ICC = 0.910; mean difference 1.08% [−7.90; 10.06]) was good. Inter-observer agreement
for effective flow (ICC = 0.935; mean difference 2.12 ml [−15.24 to 19.48]) and regurgitant fraction (ICC = 0.968;
mean difference 1.10% [−7.96 to 5.76]) were comparable. In 25/65 (38.5%) TR grade differed by at least 1 grade
using 4D-flow CMR compared to echocardiography.
Conclusion: TV effective flow derived from 4D-flow CMR showed excellent correlation to PV effective flow
derived from 2D-flow CMR, and was reproducible to measure TV flow and regurgitation. Twenty-five out of 65
patients (38.5%) were classified differently by at least one TR grade using 4D-flow CMR compared to
echocardiography.
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Background
Tricuspid valve (TV) regurgitation (TR) frequently compli-
cates pulmonary hypertension (PH) and congenital heart
defects (CHD) associated with right ventricular (RV) pres-
sure or volume overload. The presence and severity of TR
in these patient groups is independently associated with
both increased morbidity and increased mortality [1–3].
The complex structure of the valve and the degree of
motion throughout the cardiac cycle make assessment of
TR severity difficult. When the right ventricle (RV) dilates,
RV geometry is altered, making valve structure and flow
patterns even more difficult to evaluate [4]. Severity of TR
is primarily assessed using qualitative and semi-quantitative
(color) Doppler echocardiography [5, 6]. However, these
measurements are less well validated for TR than for other
valvular regurgitations and have high inter-observer vari-
ability [5, 7, 8]. Consequently, if only echocardiography is
used, there is substantial risk of misjudging severity of TR
[8], influencing clinical decision-making.
Cardiovascular magnetic resonance imaging (CMR), using
2D velocity-encoded imaging (2D-flow), is the reference
standard for assessment and follow-up of aortic and pul-
monary regurgitation in patients with CHD [9]. However,
for both atrioventricular valves, direct flow measurement
with 2D-flow CMR is regarded as less reliable [9, 10], mostly
due to the large degree of valvular through-plane motion
[11, 12]. Alternatively, indirect quantification – combining
planimetric RV stroke volume and direct flow measurement
across the pulmonary valve (PV) – is used, but this
approach also introduces multiple sources of error [12, 13].
Four-dimensional velocity-encoded (4D-flow) CMR en-
codes velocity simultaneously in three orthogonal directions,
thereby enabling direct flow measurement, perpendicular
to the annular plane, throughout the entire cardiac
cycle [10, 14]. Tricuspid flow measurement by 4D-flow
CMR has been validated in patients with normal RVs,
as well as in patients with tetralogy of Fallot without
TR [14, 15]. However, to the best of our knowledge, a
validation study in patients with complex RV geometry
and varying degrees of TR has not been done. Further-
more, it is unknown to what extent TR grade by TV
4D-flow CMR differs from the current clinical standard
for assessing TR; echocardiography.
The aims of the present study were: 1) to correlate
effective flow across the TV measured by 4D-flow CMR
to 2D-flow derived effective flow across the PV, in
patients with complex RV geometry; 2) to assess repro-
ducibility of 4D-flow measurement across the TV, and 3)
to compare TR grade by 4D-flow CMR to TR grade by
echocardiography.
Methods
A prospective, cross-sectional study was performed in
three tertiary referral hospitals including healthy subjects
(n = 21), patients with pulmonary hypertension (PH;
n = 30), patients with isolated valvular pulmonary stenosis
(PS) or tetralogy of Fallot (n = 21) and systemic RV patients
(n = 16). CMR and transthoracic echocardiography were
performed at a single center by dedicated and experienced
staff.
In- and exclusion criteria
The PH group comprised only patients with pre-capillary
pulmonary hypertension – either idiopathic pulmonary
arterial hypertension or chronic thromboembolic pulmon-
ary hypertension. In all PH patients, the diagnosis of pre-
capillary PH had been previously confirmed by right heart
catheterization. Pre-capillary PH was defined as mean pul-
monary artery pressure of ≥ 25 mmHg and a pulmonary
capillary wedge pressure of ≤ 15 mmHg [16]. All PH
patients were on PH-specific therapy when entering the
study. The CHD cohort consisted of two major groups:
1) patients with a systemic RV either after atrial switch
procedure for transposition of the great arteries or con-
genitally corrected transposition of the great arteries,
and 2) patients with isolated valvular pulmonary sten-
osis (PS) or tetralogy of Fallot with pulmonary valvular or
homograft stenosis. Patients with contra-indications for
CMR were excluded. A group of healthy subjects between
18 and 60 years old served as control population. Subjects
were screened using physical examination, medical history
and electrocardiogram and excluded if these investigations
or subsequent CMR and echocardiogram showed any
abnormalities.
The study protocol conformed to the ethical guidelines
of the 1975 Declaration of Helsinki. The medical ethics
committees of all participating centers approved the study
and written informed consent was obtained from all
participants prior to inclusion.
General patient data
Demographic data, electrocardiogram (ECG), basic
echocardiographic measurements and functional cap-
acity were obtained for each patient. Echocardiography
and CMR were performed consecutively with less than 1 h
in between investigations. Patients and controls did not use
medication between investigations, nor did they perform
any strenuous physical activity.
Cardiovascular magnetic resonance imaging
Cine imaging, 2D flow imaging & functional analysis
All participants were imaged using a pre-defined imaging
protocol without sedation. A commercially available 1.5-T
CMR system (Ingenia R4.1.2; Philips Healthcare, Best, the
Netherlands) was used, with a dedicated chest phased-array
parallel-imaging capable surface coil. Balanced steady-state
free precession cine images were acquired in various
orientations during repeated end-expiratory breath holds.
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Multi-slice cine short-axis acquisitions were acquired from
the apex up to and including the atrioventricular valves
and the entire left ventricle and RV. The following se-
quence parameters were used: TR/TE 3.4/1.69 ms, voxel
size 1.3 × 1.3 × 8.0 mm, flip angle: 55o and a temporal reso-
lution of 30 phases per cardiac cycle. Effective flow was
measured at the level of the pulmonary valve - or aortic
valve in case of systemic RV – using 2D-flow CMR with a
retrospectively ECG-gated, velocity-encoded phase-
contrast sequence (TR/TE 5.2/3.1 ms, voxel size 2.5 ×
2.5x8mm, flip angle 12o, field of view 320, matrix 128 ×
100, 20 phases per cardiac cycle). The VENC was set to
150 cm/s, in case of a PS it was individually adapted to
yield images without aliasing artifacts.
RV volumetric analysis was performed as previously
described, by manual tracing of endocardial and epicar-
dial contours in end-diastolic and end-systolic phase in
all slices, using Qmass MR Research edition (version 7.4,
Medis, Leiden, The Netherlands), excluding the trabeculae
and papillary muscles from the ventricular blood pool
volume [17].
The following parameters were determined for the RV:
end-diastolic volume (EDV), end-systolic volume (ESV),
stroke volume (SV), ejection fraction (EF) and RV mass.
Quantification of 2D flow across the pulmonary valve (or
aortic valve in systemic RVs) was performed using Medis
Qflow (version 5.5, Medis, Leiden, the Netherlands) and
used to calculate the effective flow across the pulmon-
ary valve (2D-flow PV). All volumetric data were
indexed for body surface area. At end-diastole the max-
imum tricuspid annular diameters were measured in cine
RV 2-chamber and 4-chamber views.
4-dimensional velocity encoded CMR
For planning purposes 4-chamber, 2-chamber (of both
ventricles) and perpendicular views of each of the four
cardiac valves were used – to ensure that the 4D-flow
volume would enclose all valves during diastole and systole.
Velocity data were acquired in three orthogonal directions.
The 4D-flow CMR acquisition was based on the protocol
previously described by Westenberg et al. [14]. The follow-
ing acquisition parameters were used: TR/TE 7.3/3.9 msec,
respectively; field of view 370 × 219 × 63 mm; 3D volume
imaging with 63-mm slab thickness reconstructed into 28
3.5 mm slices; 10° flip angle; acquisition voxel 3.43 × 3.65 ×
3.5 mm; reconstructed voxel size 2.9 × 2.9 × 3.5 mm; 1 sig-
nal acquired; retrospective gating with 20-30% acceptance
window, with 30 phases reconstructed during 1 average
cardiac cycle; maximal velocity encoding of 150 cm/s in all
three directions. To reduce acquisition time, echo planar
imaging was used with a factor of 5.
Analysis of through-plane flow across the TV was per-
formed with Mass (version 5.1, Medis) In short, the TV
plane was reconstructed in each cardiac phase using two
orthogonal planes, perpendicular to the flow across the
TV (Fig. 1 a-d). After the valve plane was reconstructed
for each phase of the cardiac cycle, the through-plane
flow was reformatted in five parallel planes with a slice
gap of 5 mm. Subsequently, contours were drawn outlin-
ing the flow of the valve of interest (Fig. 1-e&f) for each
phase. Through-plane motion correction using the vel-
ocity of myocardium was taken into account by a indi-
cating a region of interest in the myocardium. Finally,
forward and backward flow, regurgitant fraction and ef-
fective flow were derived from 4D-flow CMR. To illus-
trate the impact of measurement plane reconstruction
perpendicular to the flow direction in 4D-flow CMR, we
performed flow analysis using a static tricuspid valvular
plane in 15 random datasets (i.e. in essence comparable
to 2D-flow across the TV).
To assess the accuracy of the 4D flow measurement
across the TV, 4D-flow derived TV effective flow
was compared to the current reference: 2D-flow
derived pulmonary effective flow. Severity of TR was
classified according to regurgitation fraction: 0-10%
(absent/trace); 10-20% (mild); 20-40% (moderate); >
40% (severe) [18].
Echocardiography
Echocardiography was performed using a Toshiba Artida
system (Toshiba, Tokyo, Japan) with a 5-MHz transducer.
Analysis was performed offline in XCelera (version
4.1.1.1133 - 2013; Philips Healthcare). RV systolic pres-
sure (RVSP) was calculated using the Bernoulli equa-
tion with maximum velocity of TR or by maximal
pulmonary valve gradient (only in PS patients with
valvular stenosis), plus estimated right atrial pressure.
In systemic RV patients the systemic systolic blood
pressure at rest was used as RVSP. Tricuspid annular
plane systolic excursion (TAPSE) and systolic velocity
using tissue (TDI S′) Doppler imaging were measured
in 4-chamber view.
TR was visualized in a parasternal 2-chamber RV, para-
sternal short axis aorta orientation, subcostal and in the
modified apical 4-chamber view – if possible an apical 2-
chamber-RV view was also used. To quantify TR the follow-
ing parameters were taken into account: vena contracta,
early tricuspid inflow velocity, hepatic vein systolic flow
reversal, color Doppler flow jet area and density of TR
Doppler signal [19]. The severity of TR was graded none/
trace, mild, moderate or severe based on these (semi-) quan-
titative and qualitative assessment - by an experienced
imaging-cardiologist (F.M.) blinded to 4D-flow CMR results.
Reproducibility
To assess intra-observer reproducibility 15 patients were
re-analyzed by the first observer (CMR - M.S.; echocar-
diography – F.M.). Inter-observer reproducibility was
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assessed in the same 15 patients by a second observer
(CMR - M.D.; echocardiography – G.S.). Both observers
were blinded for the previous results and the first and
second analysis were at least 1 month apart.
Statistical analysis
For all continuous variables, the distribution was tested
using the Shapiro-Wilk test and by plotting histograms.
Continuous data were expressed as mean value ± standard
deviation (SD) or median [range] as appropriate. Continu-
ous data were compared between groups using ANOVA
with posthoc Dunnet’s test or the Kruskal Wallis analysis
of variance, depending on distribution of data and resid-
uals. Categorical data was presented as absolute number
followed by percentage, the agreement of TV regurgita-
tion grade by echocardiography and 4D-flow CMR and
reproducibility measurements for echocardiography, was
assessed using linear weighted Kappa (< 0.2 slight, 0.2-0.4
fair, 0.4-0.6 moderate, 0.6-0.8 considerable and >0.80
almost perfect agreement).
Agreement between 2D-flow derived PV effective stroke
volume and 4D-flow CMR derived TV effective SV as well
as between repeated measures was assessed using
intraclass correlation coefficients (ICC) and paired-
samples T-test. Furthermore, Bland Altman plots were
constructed. All data analyses were performed in SPSS
statistics (version 20.0, International Business Machines,
Inc., Chicago, Illinois, USA). P-values of <0.05 were con-
sidered statistically significant.
Results
Demographic data
All demographic and baseline data are listed in Table 1.
In short, PH patients were older than the control group
and CHD patients. Patients with systemic RVs had the
highest RVSP. Basic volumetric measurements are also
listed in Table 1; RV volumes were increased in systemic
RV and PH patients compared to controls.
4D-flow and 2D-flow CMR measurements are depicted in
Table 2. Acquisition time for the 4D-flow CMR dataset was
3.5-7 min; acquisition time of cine CMR images necessary
for post-processing was approximately 7 min. Lastly,
acquisition time for echocardiographic images related to as-
sessment of TR was approximately 15 min. Analysis time
for 4D-flow CMR across the TV was approximately 35 min
per patient; analysis with a static plane (2D TV flow) was
approximately 10 min. Analysis of TR grade on echocardi-
ography took on average 6 min per patient.
Accuracy of 4D-SV TV compared to reference 2D-SV PV
TV 4D-flow CMR analysis was possible in 67/67 patients
(100%). Effective flow measured across the TV by 4D-flow
CMR could be compared to 2D-flow derived effective flow
across the PV in 85/88 subjects, due to poor quality of 2D-
flow images in three subjects (Fig. 2a-c). The intra-class
correlation coefficient between both measurements was
0.90 (95% confidence interval 0.85-0.94; p < 0.001) and the
R2 was 0.83. Mean difference in 4D-flow derived TV effect-
ive flow vs 2D-flow derived PV effective flow was −1.6 ml
(p = 0.083) with limits of agreement: −20.0 to 16.8 ml.
Fig. 1 Example of 4D flow. Example of 4D-flow CMR analysis. In a-d the annular plane is reconstructed perpendicular to the flow direction, in fig-
ure e + f the flow contours are drawn in the reconstructed through-plane flow slice
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Analysis of TV effective flow, using a static annular
plane – similar to TV 2D flow method – was performed
in 15 datasets. Intra-class correlation coefficients for TV
2D-effective flow vs. PV 2D-effective flow, TV 2D-
effective flow vs. TV 4D-effective flow and TV regurgi-
tant fraction using 2D flow vs. 4D-flow were respectively
0.666 (p < 0.001), 0.767 (p < 0.001) and 0.389 (p = 0.002).
Effective flow was significantly overestimated by TV 2D-
flow compared to both other methods (p < 0.001; Fig. 3),
regurgitant fraction was significantly underestimated
(p < 0.001; Fig. 3).
Reproducibility
Reproducibility measurements are listed in Table 3
and are shown in Fig. 4. Both intra- and interobserver
measurements yielded good intra-class correlation
coefficients (all > 0.91 and p < 0.001) for TV 4D-flow
CMR. Mean intra- and interobserver differences in
forward flow and effective flow were small with good
limits of agreement (Table 3). The mean difference
and limits of agreement for measurement of TR (%)
were acceptable for both intra- and inter-observer
measurements (1.08% [−7.90; 10.06] and −1.10%
[−7.96; 5.76], respectively).
Reproducibility of echocardiography showed a kappa
value of 0.57 (95% CI 0.30-0.84) for intra-observer agree-
ment and 0.66 (95% CI 0.39-0.92) for inter-observer
agreement. During second observation TR grade was
classified differently in 6/15 (= 40%) of patients by the
same observer, and in 5/15 (= 33%) by a second observer.
Table 1 Demographic data
Controls (n = 21) CHD
(n = 37)
PH
(n = 30)
p-value
PS (n = 21) SystRV (n = 16)
Age (yrs) 41.2 ± 10.5 30.6 ± 12.6# 36.6 ± 8.4 54.4 ± 15.6** <0.001
BSA (m2) 1.93 ± 0.21 1.90 ± 0.15 1.94 ± 0.15 1.92 ± 0.26 0.97
RVSP (mmHg) – 50 [40-111] 108 [89-127] 54 [23-100] 0.025
VO2/kg (ml/min) – 29.7 ± 6.6 27.1 ± 6.6 17.0 ± 4.1 <0.001
%PredVO2/kg – 83.8 ± 17.2 83.0 ± 18.5 62.9 ± 12.9 <0.001
QRS (msec) 93.1 ± 13.7 133.1 ± 34.4** 107.2 ± 16.2 97.5 ± 24.2 <0.001
Heart rate 61 ± 9 69 ± 9 59 ± 8 69 ± 12 0.013
RVEDV (ml/m2) 97 [60-134] 95 [71-170] 109 [73-222] 110 [52-343] 0.48
RVESV (ml/m2) 46 [20-59] 49 [26-122] 58 [26-170] * 60 [16-271]* 0.009
RVEF (%) 54.8 ± 4.6 49.0 ± 9.2 45.5 ± 10.7# 41.1 ± 11.4** 0.017
General demographic data for all groups. To test for differences between the different groups (last column) ANOVA with posthoc Dunnets (controls as reference)
was used for normally distributed data and Kruskal Wallis analysis of variance with Mann Whitney U tests for non-normally distributed data. #p < 0.05, *p < 0.01,
**p < 0.001. Abbreviations: BSA body surface area, RVSP right ventricular systolic pressure, VO2/kg peak oxygen uptake per kg, %PredVO2/kgg % of predicted peak
oxygen uptake, RV right ventricular, EDV end-diastolic volume ESV end-systolic volume, EF ejection fraction
Table 2 CMR measurements
Controls (n = 21) CHD
(n = 37)
PH
(n = 30)
PS (n = 21) Syst RV (n = 16) p-value
4D-TV FW (ml) 111.5 ± 27.3 91.2 ± 15.2# 95.4 ± 19.8 87.2 ± 21.7** 0.23
4D-TV BW (ml) 8.3 [2.0-24.1] 8.4 [5.1-25.9] 10.7 [3.7-34.0] 7.3 [2.2-57.7] 0.61
4D-SV TV (ml/m2) 52.4 ± 9.4 42.5 ± 5.7** 41.7 ± 8.0** 38.7 ± 9.6** 0.13
4D-TV reg (%) 7.9 [1.9-17.6] 9.3[5.4-25.0] 12.5 [5.1-40.1] 9.2 [3.2-49.6] 0.307
2D-SV PA (ml/m2) 49.5 ± 7.7 42.1 ± 4.8* 42.8 ± 7.5# 38.0 ± 9.6** <0.001
TVann 4CH (mm) 37.4 ± 4.1 38.8 ± 5.8 42.3 ± 5.0* 39.6 ± 4.4 0.032
TVann 2CH (mm) 37.5 ± 4.3 37.7 ± 5.3 38.5 ± 4.5 38.5 ± 3.6 0.84
Results of volumetric and 4D flow CMR
To test for differences between the different groups (last column) ANOVA with posthoc Dunnets (controls as reference) was used for normally distributed data
and Kruskal Wallis analysis of variance with Mann Whitney U tests (controls as reference) for non-normally distributed data. #p < 0.05, *p < 0.01 and **p < 0.001.
Abbreviations: 4D-TV FW 4D tricuspid valve forward flow, 4D-TV BW 4D tricuspid valve backward flow, 4D-SV TV 4D tricuspid valve effective flow, 4D-TV reg 4D flow
tricuspid valve regurgitation, 2D-SV PA 2D pulmonary valve effective flow, TVann 4CH tricuspid annulus diameter in 4-chamber view, TVann 2CH tricuspid valve
annulus diameter in 2-chamber view
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TR grade by 4D-flow CMR vs echocardiography
Severity of TR could be graded by 4D-flow CMR in all
67 patients, and in 65/67 (97%) patients by echocardiog-
raphy. Of these patients, 40/65 patients (61.5%) showed
consistent results for echo and 4D-flow CMR, but 25/65
(38.5%) were classified differently by at least 1 grade using
4D-flow CMR compared to echocardiography (Table 4).
Both methods showed only moderate agreement; with a
linear weighted kappa of 0.52 (95%-confidence interval
0.37-0.67).
A trace to mild TR grade by echocardiography excludes
moderate or severe TV regurgitation by 4D-flow CMR in
95% of patients (=negative predictive value). However,
moderate or severe TR grade by echocardiography corre-
sponded to a moderate or severe TR grade by 4D-flow
CMR in only 60% of patients (=positive predictive value).
Of the 14 patients with moderate or severe TR on echo-
cardiography or 4D-flow CMR, 2 could not be classified
Fig. 2 Accuracy of 4D-flow CMR. a) depicts the correlation between
effective flow across the tricuspid valve using 4D-flow CMR (4D-flow
TV) and effective flow across the pulmonary valve using 2D-flow CMR
(2D-flow PV). b) depicts a Bland-Altman analysis with the difference
between both effective flow measurements on the x-axis and the
average of both measurements on the y-axis
Fig. 3 Tricuspid valve 2D-flow versus 4D-flow. Bland-Altman plots of
tricuspid valve effective flow using a static annular plane (similar to
2D flow) versus effective flow across the pulmonary valve (a) and
versus 4D flow (b). c) depicts tricuspid regurgitant fraction using a
static annular plane (2D flow on y-axis) versus 4D flow (x-axis)
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by echocardiography and 9/12 (75%) were classified differ-
ently by both methods.
Discussion
In this study, we assessed the feasibility, accuracy and
reproducibility of 4D-flow CMR derived TV flow in
patients with RV heart disease and varying degrees of
TV regurgitation. Four-dimensional-flow derived TV
flow proved to be feasible in all patients and correlated
well to our reference standard 2D-flow derived PV effective
flow. Furthermore, reproducibility of flow volumes and
regurgitation by 4D-flow CMR were good, even in this
complex patient population. In 25/65 (38.5%) of the
patients, 4D-flow CMR led to a different grading of TR
compared to echocardiography.
4D-flow CMR of the tricuspid valve
In our patient cohort, effective flow across the TV mea-
sured with 4D-flow CMR showed excellent correlation
to effective flow across the PV measured with 2D-flow
CMR. This is true for both patient groups (ICC 0.870) as
well as healthy controls (ICC 0.895). Conversely, TV flow
measured without reconstruction of a measurement plane
perpendicular to the flow (similar to 2D flow CMR), sig-
nificantly overestimated effective flow volume compared to
the PV effective flow. Our results are in line with previous
reports on 4D-flow CMR derived TV flow in patients
without RV heart disease, by Westenberg et al., and those
with tetralogy of Fallot without TR, by van der Hulst et al.
[14, 15]. The limits of agreement for effective flow (i.e.
stroke volume) between TV 4D-flow CMR and PV 2D-
flow CMR varied between −20.0 to +16.8 ml. These values
are acceptable, as even for repeated 2D-flow measurements
of semi-lunar valves there is considerable inter-observer
and interscan variation [20, 21]. For example, Kondo et al.
reported a relative difference of 7.0 ± 5.6% for repeated PV
2D-flow CMR measurements [21]. The difference between
4D-flow CMR derived TV flow and 2D-flow CMR derived
Table 3 Intra- and interobserver agreement
Mean Δ p-value1 ICC p-value2
Intraobserver
Forward flow (ml) 1.08 ± 4.58 0.911 0.963 <0.001
Stroke volume (ml) −1.51 ± 5.80 0.329 0.981 <0.001
Regurgitance (%) −1.07 ± 4.58 0.378 0.910 <0.001
Interobserver
Forward flow (ml) 1.44 ± 9.26 0.370 0.911 <0.001
Stroke volume (ml) 2.12 ± 8.86 0.556 0.935 <0.001
Regurgitance (%) −1.1 ± 3.5 0.242 0.968 <0.001
Mean difference (Δ) between repeated measures and significance were tested
with a paired Student T-test and agreement using intra-class correlation
coefficient (ICC)
1p-value using paired Student's T test
2p-value for intra-class correlation coefficient (ICC)
Fig. 4 Reproducibility of 4D flow CMR measurements. a&b Bland-Altman analysis of intra-observer repeated measurements of effective flow
(a) and regurgitation (b). c&d Bland-Altman analysis of inter-observer repeated measurements of effective flow (c) and regurgitation (d)
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PV flow can further be explained by several other factors:
1) 2D-flow suffers from some through plane movement; 2)
2D-flow across the PV was obtained during end-expiratory
breath-hold while 4D-flow CMR was obtained during
free-breathing and 3) interscan variability (although time
between acquisitions was < 10 min).
Thus far, reproducibility measurements have been mostly
obtained in patients with structurally normal hearts or
focused on other applications of 4D-flow imaging (i.e. peak
flow velocity and wall stress) [14, 22]. In patients with RV
dilation and hypertrophy, TV geometry is distorted [4].
Hence, reproducibility of 4D-flow CMR derived TV flow in
this population cannot be extrapolated from healthy
subjects or patients with structurally normal hearts.
The present study fills this gap and demonstrates good
intra-observer and inter-observer agreement with accept-
able limits of agreement and excellent ICC coefficients
(all >0.90). The reproducibility in our cohort is comparable
to limits of agreement reported in TV flow of healthy
controls by Westenberg et al. and 2D-flow imaging of
pulmonary or aortic valves [20, 21].
Echocardiography vs 4D-flow CMR
We demonstrate a discrepancy between 4D-flow CMR
and echocardiographic TR grading in our patient cohort.
Twenty-five out of 65 patients (38.5%) were classified
differently by at least one grade using quantitative 4D-flow
CMR TR measurements compared to echocardiographic
assessment. Importantly, this number was even higher in
patients with severe or moderate TR (namely 9/12 = 75%
of patients). With the lack of a gold standard it is difficult
to be sure which of these techniques provides the most
accurate results. However, TV flow assessment by 4D-
flow CMR has been validated both in vitro and in vivo
[10, 14, 23] and TR grading by echocardiography has
shown less consistent results [5, 7, 8], which may indicate
4D-flow CMR is more reliable. Adding to this, agreement
between repeated measures was very good (ICC > 0.9) for
repeated 4D-flow measurements, but only moderate to
considerable (Kappa 0.57 and 0.66) for repeated TR grade
by echocardiography. Importantly, a trace to mild TR grade
by echocardiography still excludes moderate or severe TV
regurgitation by 4D-flow CMR in 95% of patients.
Clinical implications
As is the case for many other measurements of RV size
and function, echocardiography is an excellent screening
tool. However, for assessment of degree of TV regurgita-
tion, 4D-flow CMR seems of added value. If moderate or
severe TR is seen on echocardiography, additional as-
sessment of TR by means of 4D-flow CMR may help
or guide clinical decision-making. In patients in whom
surgery is considered, TR grading using 4D-flow CMR
may improve selection of patients that potentially
benefit from TV annuloplasty [24–27]. Moreover, the
detailed anatomical information obtained with 4D-flow
CMR (Fig. 1) may be helpful in identifying the mech-
anism of regurgitation and planning of intervention.
In both pulmonary hypertension patients and in CHD
the degree of TR is related to symptoms and mortality
[1–3, 28]. Accurate determination of the degree of TR can
help physicians better understand a patients’ physiology and
ensure timely referral of patients for surgery or transplant.
Limitations
This study has limitations. First, 4D-flow CMR post
processing and analysis remains time-consuming and
labor-intensive (35 min), limiting its use in clinical
practice for many institutions. Currently, validation of
semi-automated software is underway – shortening
post-processing times and making analysis less user-
dependent [29]. Furthermore, in addition to observer
variability, interscan variability will need to be evaluated in
future studies.
Table 4 Echocardiography vs 4D-flow CMR
Contingency table depicting the results for TR grading by echocardiography versus 4D-flow CMR (clinically most relevant group, with either moderate or severe
TR, highlighted). The linear weighted kappa for agreement between both methods was 0.52 (95%-confidence interval 0.37-0.67)
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The number of patients with moderate to severe TR
was limited, which may limit its application in these
patients.
We chose to use 2D-flow CMR derived PV flow as
reference measurement for stroke volume, introducing
interscan variability and through plane motion. Inva-
sively measured stroke volumes across the pulmonary
valve were not available. We did not use 4D-flow CMR
for PV flow as many of our patients had severe PS with
a large degree of aliasing or a homograft – for which
4D-flow CMR is not yet validated.
Conclusion
In patients with complex RV morphology, 4-D flow CMR
is a reproducible method to measure TV flow and regurgi-
tation and effective flows showed excellent correlation to
2D-flow CMR across the PV. Twenty-five out of 65
patients (38.5%) were classified differently by at least
one grade using quantitative 4D-flow CMR TR grading
compared to echocardiographic assessment. However, a
trace to mild TR by echocardiography excludes moderate
or severe TR by 4D-flow CMR in 95% of patients. As
software developments accelerate 4D-flow CMR post-
processing, it can provide a reproducible method of
grading TR in clinical practice and future studies.
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